Upcoming GPBCH Events

Coverage from the 64th Annual American Society of Hematology Meeting and Exposition, December 10-13, 2022, New Orleans, Louisiana.

On this episode of Managed Care Cast, we speak with Tom Stanis, CEO and cofounder of Story Health, and Phillip Wood, Intermountain Ventures program director, on how their partnership came about, how it is going so far, and the future of their collaboration.

In abstracts presented at the 64th American Society of Hematology Annual Meeting and Exposition, the investigational BTK inhibitor pirtobrutinib showed promising efficacy and safety in several types of B-cell lymphoma.

On this episode of Managed Care Cast, Consuelo Wilkins, MD, MSCI, discusses efforts to improve racial and ethnic disparities in US chronic disease rates.

An analysis presented during the 64th American Society of Hematology Annual Meeting and Exposition showed that patients with multiple myeloma were able to experience improved responses to the proteasome inhibitor ixazomib after switching from bortezomib.

A new study highlighted that patients with diabetes enrolled in Medicare Advantage (MA) had better outcomes compared with patients in traditional fee-for-service (FFS) Medicare.